3-(7-amino-11-pyrazol-1-yl-3-oxa-12-thia-5,8-diazatricyclo[7.3.0.02,6]dodeca-1(9),2(6),4,7,10-pentaen-4-yl)propan-1-ol
C14H13N5O2S — CID 146253438
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(7-amino-11-pyrazol-1-yl-3-oxa-12-thia-5,8-diazatricyclo[7.3.0.02,6]dodeca-1(9),2(6),4,7,10-pentaen-4-yl)propan-1-ol
3-(7-amino-11-pyrazol-1-yl-3-oxa-12-thia-5,8-diazatricyclo[7.3.0.02,6]dodeca-1(9),2(6),4,7,10-pentaen-4-yl)propan-1-ol (PubChem CID 146253438) has the molecular formula C14H13N5O2S and a molecular weight of 315.36 g/mol. Its IUPAC name is 3-(7-amino-11-pyrazol-1-yl-3-oxa-12-thia-5,8-diazatricyclo[7.3.0.02,6]dodeca-1(9),2(6),4,7,10-pentaen-4-yl)propan-1-ol.
Molecular Properties
| Compound Name | 3-(7-amino-11-pyrazol-1-yl-3-oxa-12-thia-5,8-diazatricyclo[7.3.0.02,6]dodeca-1(9),2(6),4,7,10-pentaen-4-yl)propan-1-ol |
|---|---|
| PubChem CID | 146253438 |
| Molecular Formula | C14H13N5O2S |
| Molecular Weight | 315.36 g/mol |
| Exact Mass | 315.08 |
| IUPAC Name | 3-(7-amino-11-pyrazol-1-yl-3-oxa-12-thia-5,8-diazatricyclo[7.3.0.02,6]dodeca-1(9),2(6),4,7,10-pentaen-4-yl)propan-1-ol |
| SMILES | Nc1nc2cc(-n3cccn3)sc2c2oc(CCCO)nc12 |
| InChI | InChI=1S/C14H13N5O2S/c15-14-11-12(21-9(18-11)3-1-6-20)13-8(17-14)7-10(22-13)19-5-2-4-16-19/h2,4-5,7,20H,1,3,6H2,(H2,15,17) |
| InChIKey | PERZIHLHQUMANI-UHFFFAOYSA-N |
| XLogP | 2.13 |
| TPSA | 102.99 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 22 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 315.36 |
| LogP ≤ 5 | 2.13 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146253438 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.